More on aprepitant for erlotinib-induced pruritus

New England Journal of Medicine

Volumn 364, Issue 5, 2011, Pages 487-

  Mir, Olivier ^a   Blanchet, Benoit ^a   Goldwasser, François ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APREPITANT; CYTOCHROME P450 3A4; ERLOTINIB; ETIRACETAM; PREDNISONE;

ADULT; CASE REPORT; CLINICAL ASSESSMENT; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ERUPTION; DRUG EXPOSURE; DRUG SAFETY; HUMAN; HYPOTHESIS; LETTER; LIQUID CHROMATOGRAPHY; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PRURITUS; TREATMENT RESPONSE; TRICHOMEGALY;

ADENOCARCINOMA; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; MORPHOLINES; OFF-LABEL USE; PROTEIN KINASE INHIBITORS; PRURITUS; QUINAZOLINES; RECEPTORS, NEUROKININ-1;

EID: 79551506206     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)